Oncology PRO European Society for Medical Oncology (ESMO)
MENU SIGN IN
Become an ESMO member SIGN IN
European Society for Medical Oncology (ESMO)
provided by ESMO
  • Oncology News
    • Videos from Conferences archive
    • OncologyPRO satisfaction rate...
    • Daily News
    • ESMO Videos
    • What's new on OncologyPRO?
    • OncologyPRO structure explained

    OncologyPRO satisfaction rate is 96% from the result of a June 2018 online survey

    A recent survey showed that OncologyPRO users’ satisfaction rate is over 95%

    Daily News

    OncologyPRO, in partnership with medwireNews, brings you updates each day in the field of medical oncology.

    ESMO Videos

    Watch leading oncology experts sharing knowledge in ESMO educational videos or reporting on recent study results presentation.

    What's new on OncologyPRO?

    Haven't had much time lately? Here's what you may have missed in the last few weeks.
    Sign-up to receive the OncologyPRO alert every 2 weeks.

     

    OncologyPRO structure explained

    OncologyPRO has evolved in July 2017 to offer you direct access to our rich content either by tumour site or according to the objectives of your visit.

  • Guidelines
    • Clinical Practice Guidelines
    • Pocket Guidelines & Mobile App
    • ESMO Consensus Conferences

    Clinical Practice Guidelines

    New 2018 ESMO Clinical Practice Guidelines now online!

    Pocket Guidelines & Mobile App

    Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients

    ESMO Consensus Conferences

    ESMO Consensus Conferences discuss key questions in certain disease areas and complement the ESMO Clinical Practice Guidelines

  • Oncology in Practice
    • Practice Tools
    • Anti-Cancer Agents and Biologi...
    • Bioethics, legal and economic...
    • Cancer Aetiology, Epidemiology...
    • Cancer Immunology and Immunoth...
    • Cancer in Special situations (...
    • Imaging, Diagnosis and Staging
    • Palliative and Supportive care
    • Pathology and Molecular Biology
    • Personalised Medicine
    • Surgery and / or Radiotherapy
    • Translational Research: Biomar...
    • Rare Cancers
    • Resources for Patients

    Practice Tools

    ESMO has developed a set of organ-specific tools designed to assist oncologists in their daily practice.

    Anti-Cancer Agents and Biological Therapy

    Find the essential information, user-friendly publications and resources presenting recent developments on these treatments

    Bioethics, legal and economic issues

    Access ESMO scientific and educational resources on this topic

    Cancer Aetiology, Epidemiology and Prevention

    Find ESMO publications, meeting resources, experts' interviews and more on this subject.
    "Oncologists have the potential to be a large & important group of activists for cancer prevention measures " D.J. Kerr, MD

    Cancer Immunology and Immunotherapy

    Get information on recent advances in cancer immunology & immunotherapy and keep up with treatment opportunities for your patients

    Cancer in Special situations (pregnancy, young, elderly, hereditary...)

    All ESMO scientific and educational resources on

    • Cancer in Adolescents / Young Adults
    • Cancer in Pregnancy
    • Geriatric Oncology
    • Familial Cancer
    • ...

    Imaging, Diagnosis and Staging

    Access ESMO scientific and educational resources on this topic

     

    Palliative and Supportive care

    All ESMO scientific and educational resources on

    • Supportive Care
    • Palliative Care
    • Complications of Treatment
    • Psychosocial aspect of Cancer

    Pathology and Molecular Biology

    Access ESMO scientific and educational resources on this topic

    Personalised Medicine

    Access ESMO scientific and educational resources on this topic

    Surgery and / or Radiotherapy

    Access ESMO scientific and educational resources on this topic

    Translational Research: Biomarkers & Diagnostics

    Access ESMO scientific and educational resources on this topic

    Rare Cancers

    Access ESMO scientific and educational resources on this topic

    Resources for Patients

    Useful information and updates created by ESMO for cancer patients

  • Education Library
    • Discover ESMO journals
    • Essentials for Clinicians
    • Handbooks
    • ESMO E-Learning and V-Learning
    • Factsheets on Anti-Cancer Agents
    • Factsheets on Biomarkers
    • Clinical Trial Resources
    • Educational Slides
    • Glossary of Molecular Biology
    • Glossary of Precision Medicine
    • Cancer in Medical Journals
    • User’s Manual for Oncology Cli...
    • Abbreviations
    • Links to Cancer Journals
    • Global Curriculum in Medical O...

    Discover ESMO journals

    ESMO has three distinctly unique oncology journals: Annals of Oncology, ESMO Open and Immuno-Oncology Technology (IOTECH).

    ESMO Members: ESMO's flagship journal, Annals of Oncology, is freely available to you. Please login to gain access !

    Essentials for Clinicians

    A simplified yet comprehensive overview on oncological malignancies, their biology, diagnosis, staging, treatment and follow-up, which are necessary for basic patient treatment

     

    Handbooks

    ESMO members: the recent ESMO Handbooks are available for browsing online to allow you to easily access the sections most relevant to you.

    ESMO E-Learning and V-Learning

    Watch E-Learning and V-Learning webcasts produced by leading oncology experts and take the CME test.
    Our open library offers over 80 modules!

    Factsheets on Anti-Cancer Agents

    Find here all the information related to anti-cancer agents as described in the ESMO Handbook on Clinical Pharmacology of Anti-Cancer Agents.

    Factsheets on Biomarkers

    ESMO has developped factsheets of validated biomarkers designed to assist you in your daily practice. They give statements on prognostic value, predictive value, patient selection, testing recommendations...

    Clinical Trial Resources

    ESMO Clinical Trial Resources are designed to support you with designing, participating in and reviewing clinical trials

    Educational Slides

    Educational slides on Cancer Prevention, Clinical Trials, Colorectal Cancer and Molecular Biology

    Glossary of Molecular Biology

    ESMO members: Browse through the ESMO Glossary in Molecular Biology of Cancer and Molecular Techniques online

    Glossary of Precision Medicine

    The Precision Medicine Glossary, developed by ESMO, features 43 terms and aims to clarify the language used by oncologists and basic scientists within the context of precision medicine. 

    Cancer in Medical Journals

    Collection of links to the latest cancer related articles in top medical journals: Annals of Oncology, The Lancet, JAMA, NEJM, BMJ and Nature Medicine

    User’s Manual for Oncology Clinicians

    Discover the User's Manual for Oncology Clinicians: “Clinician’s notes” for each of the 16 chapters of the Guide for Patients with Advanced Cancer.

    Abbreviations

    Find the most common oncology abbreviations.

    Links to Cancer Journals

    Here, ESMO members can gain direct access to journals available to Annals of Oncology. You can also find links to interesting journals in the fields of Medical Oncology, Haematology and Biomarkers.

    Global Curriculum in Medical Oncology

    The 2016 edition of ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology and the 2017 edition of the associated Log Book are now available 

  • Meeting Resources
    • Meeting Resources 2018: A year...
    • ESMO Congress resources
    • Scientific Meeting Reports
    • Slide Resources

    Scientific Meeting Reports

    Meeting reports from past ESMO organised and ESMO supported meetings.

    Slide Resources

    All ESMO slide resources in one convenient location.

  • Tumour Sites
    • Breast Cancer
    • Carcinoma of Unknown Primary Site
    • Central Nervous System Maligna...
    • Endocrine Cancers
    • Gastrointestinal Cancers
    • Genitourinary Cancers
    • Gynaecological Malignancies
    • Haematological Malignancies
    • Head and Neck Cancers
    • Lung and other Thoracic Tumours
    • Melanoma and other Skin Tumours
    • Sarcomas

    Breast Cancer

    Access all ESMO scientific and educational resources on this topic.

     

    Carcinoma of Unknown Primary Site

    Access ESMO scientific and educational resources on this topic

    Central Nervous System Malignancies

    Access ESMO scientific and educational resources on this topic

    Endocrine Cancers

    Access ESMO scientific and educational resources on this topic

    Gastrointestinal Cancers

    Access ESMO scientific and educational resources on this topic

    Genitourinary Cancers

    Access ESMO scientific and educational resources on this topic

     

    Gynaecological Malignancies

    Access ESMO scientific and educational resources on this topic

    Haematological Malignancies

    Access ESMO scientific and educational resources on this topic

    Head and Neck Cancers

    Access ESMO scientific and educational resources on this topic

     

    Lung and other Thoracic Tumours

    Access ESMO scientific and educational resources on this topic

     

    Melanoma and other Skin Tumours

    Access ESMO scientific and educational resources on this topic

    Sarcomas

    Access ESMO scientific and educational resources on this topic

  • OncologyPRO
  • Education Library
  • Drug Index of ESMO 2014 Abstracts
  • Encorafenib
SHOW SIDEMENU

Encorafenib

All ESMO 2014 abstracts with reference to encorafenib are listed below

  • 535P - Encorafenib (LGX818), an oral BRAF inhibitor, in patients (pts) with BRAF V600E metastatic colorectal cancer (mCRC): Results of dose expansion in an open-label, phase 1 study
Last update: 02 September 2014
  • Discover ESMO journals
  • Essentials for Clinicians
    • Breast Cancer
      • Chapter 1 - Diagnosis and Staging of Breast Cancer and Multidisciplinary Team Working
      • Clinical Examination and Imaging
      • Percutaneous Needle Biopsy and Axillary Staging
      • Other Staging Examinations
      • Multidisciplinary Work
      • Summary and Further Reading
      • Editors and Contributors
      • Appendix 2: TNM Classification of Breast Tumours, 8th edition (2016)
    • Leukaemia and Myeloma
    • Neuro-Oncology
      • Chapter 1 - Epidemiology, Pathogenesis and Risk Factors of Brain Tumours
      • Primary CNS Tumours – Descriptive Epidemiology
      • Primary CNS Tumours – Clinical Epidemiology
      • Gliomas and Meningiomas – Risk Factors
      • Gliomas and Meningiomas – Risk Factors (Continued)
      • Summary and Further Reading
      • Editors and Contributors
      • Appendix 1: WHO Classification and Grading of Tumours of the Central Nervous System
      • Appendix 2: Selected Treatment Schedules for Neuro-Oncology
    • Head & Neck Cancers
      • Chapter 1 - Epidemiology, Risk factors and Pathogenesis of Squamous Cell Tumours
      • Growth Factor and Angiogenesis Inhibitors
      • Editors and Contributors
    • Gynaecological Tumours
      • Chapter 1 - Histopathology of Gynaecological Cancers
      • Editors and Contributors
    • Gastrointestinal Tract Tumours
      • Chapter 1 - Biology of Cancer Development in the GI Tract
      • Selected Treatment Schedules for Gastrointestinal Tract Tumours
      • Editors and Contributors
    • Genitourinary Tract Tumours
      • Chapter 1 - Anatomy of the GU Tract and Histology of GU Tumours
      • Selected Treatment Schedules for Genitourinary Tract Tumours
      • Editors and Contributors
    • Thoracic Tumours
      • Chapter 1 - Epidemiology, Pathogenesis, and Risk Factors
      • Selected Treatment Schedules for Thoracic Tumours
      • Editors and Contributors
    • Lymphomas
      • Introduction
      • Chapter 1 - The Immune System
      • Selected Treatment Schedules for Lymphomas
      • Appendix 4: List of Novel Agents
      • Editors and Contributors
      • Acknowledgements
  • Handbooks
    • Immuno-Oncology
      • Preface
      • 1.1 Immune Checkpoints
    • Interpreting Oncological Study Publications
      • Introduction: Interpreting Oncological Study Publications
      • Chapter 1 - Risk Factors
      • Editors and Contributors
    • Oncological Emergencies
      • Chapter 1 - Cardiac Complications of Cancer and Anti-Cancer Treatment
      • Acknowledgements
      • Editors and Contributors
    • Cancer Diagnosis and Treatment Evaluation
      • Chapter 1 – Introduction
      • Editors and Contributors
    • Cancer in the Senior Patient
      • Chapter 01 – Introduction
      • Editors and Contributors
    • Translational Research
      • Chapter 1 - Definition: Translational and Personalised Medicine, Biomarkers, Pharmacodynamics
      • Editors and Contributors
      • Acknowledgements
    • Rehabilitation Issues During Cancer Treatment and Follow-Up
      • Introduction
      • Chapter 01 - Safeguarding Exercise Capacity Throughout and After Cancer Treatment
      • Editors and Contributors
      • Reviewers
      • Acknowledgements
    • Cancer Treatment in Special Clinical Situations
      • Introduction
      • Chapter 1 - Cancer Treatment during Pregnancy
      • Editors and Contributors
      • Reviewers
      • Acknowledgements
    • Clinical Pharmacology of Anti-Cancer Agents
      • Introduction
      • Chapter 1 - Preclinical Drug Development
      • Factsheets on Anti-Cancer Agents
      • Editors and Contributors
      • Reviewers
      • Acknowledgements
    • Nutrition and Cancer
      • Chapter 1 - Introduction
      • Editors and Contributors
      • Acknowledgement
    • Cancer Prevention
    • Advanced Cancer Care
  • ESMO E-Learning and V-Learning
    • Treatment for Relapsing Platinum Sensitive Epithelial Ovarian Cancer
    • Present and Emerging Treatment Options in HER2/neu Overexpressing Metastatic Breast Cancer
    • Perioperative Treatment of Non Small Cell Lung Cancer
    • Geriatric Oncology: An Introduction
    • Sexuality and Intimacy after Cancer
    • The Main Ethical Problems in Oncological Practice
    • Important Pathways to Target in (Advanced) NSCLC: A Focus on ALK Inhibition in Non-Small-Cell Lung Cancer (NSCLC)
    • Important Pathways to Target in (Advanced) NSCLC: A Focus on EGFR-Inhibition and Implications for Clinical Practice
    • Overview of the Diagnosis and Treatment of GI NETs
    • Genetic Testing and Counselling in Hereditary Cancer
    • Urothelial Cell Cancer
    • Mantle Cell Lymphoma
    • Advances in Hepatobiliary Cancers
    • Double-Hit Lymphomas
    • V-Learning: BRCA Across Tumour Types
    • Next Generation Drugs in Kidney Cancer
    • Innovation in Lung Cancer Management
    • Sequencing in Metastatic Prostate Cancer Treatment
    • Metastatic Castrate-Resistant Prostate Cancer Treatment (mCRPC)
    • V-Learning: BRAF Mutations Across Cancers
    • Treatment of Locally Advanced NSCLC with Chemo-radiotherapy
    • Melanoma Adjuvant Setting
  • Factsheets on Anti-Cancer Agents
  • Factsheets on Biomarkers
    • MGMT Promoter Methylation in Glioma
    • TERT Mutations in Glioma
  • Clinical Trial Resources
    • ESMO Meetings
    • Tips and Tricks
      • Contributors
    • ESMO Clinical Trials Course
    • Useful Links
      • Clinical Trials Information
  • Educational Slides
  • Glossary of Molecular Biology
    • Contributors
  • Glossary of Precision Medicine
    • ESMO Precision Medicine Glossary
  • Cancer in Medical Journals
    • Oncology Articles in the NEJM
    • Oncology Articles in the JAMA
    • Oncology Articles in The Lancet
    • Annals of Oncology: Editor's Choice
    • Oncology Articles in BMJ
    • Oncology Articles in Nature Medicine
  • User’s Manual for Oncology Clinicians
  • Abbreviations
  • Links to Cancer Journals
    • Oncology Journals
    • Open Access Oncology Journals
    • Biomarker Journals
    • Haematology Journals
  • Global Curriculum in Medical Oncology
  • Glossary of Medical Terms
  • Sponsors
  • About OncologyPRO
  • Topics
  • Useful Links
  • Conditions of Use
  • Contact Us
  • Sitemap
ico-social_tw ico-social_fb ico-social_gplus ico-social_yt ico-social_rss ico-social_in

ESMO is a Swiss-registered not-for-profit organisation.
All funding for this site is provided directly by ESMO or via grants from the sponsors and supporters.
Via Ginevra 4, 6900 Lugano - CH © Copyright 2019 European Society for Medical Oncology All rights reserved worldwide.

Scroll